Pharmacokinetics of a novel formulation of ivermectin after administration to goats
- 1 February 2006
- journal article
- research article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 67 (2) , 323-328
Abstract
Objective—To evaluate the pharmacokinetics of a novel commercial formulation of ivermectin after administration to goats. Animals—6 healthy adult goats. Procedure—Ivermectin (200 μg/kg) was initially administered IV to each goat, and plasma samples were obtained for 36 days. After a washout period of 3 weeks, each goat received a novel commercial formulation of ivermectin (200 μg/kg) by SC injection. Plasma samples were then obtained for 42 days. Drug concentrations were quantified by use of high-performance liquid chromatography with fluorescence detection. Results—Pharmacokinetics of ivermectin after IV administration were best described by a 2-compartment open model; values for main compartmental variables included volume of distribution at a steady state (9.94 L/kg), clearance (1.54 L/kg/d), and area under the plasma concentration-time curve (AUC; 143 [ng•d]/mL). Values for the noncompartmental variables included mean residence time (7.37 days), AUC (153 [ng•d]/mL), and clearance (1.43 L/kg/d). After SC administration, noncompartmental pharmacokinetic analysis was conducted. Values of the variables calculated by use of this method included maximum plasma concentration (Cmax; 21.8 ng/mL), time to reach Cmax (3 days), and bioavailability (F; 91.8%). Conclusions and Clinical Relevance—The commercial formulation used in this study is a good option to consider when administering ivermectin to goats because of the high absorption, which is characterized by high values of F. In addition, the values of Cmax and time to reach Cmax are higher than those reported by other investigators who used other routes of administration.Keywords
This publication has 20 references indexed in Scilit:
- Influence of the route of administration on efficacy and tissue distribution of ivermectin in goatVeterinary Parasitology, 2005
- Endectocide exchanges between grazing cattle after pour-on administration of doramectin, ivermectin and moxidectinInternational Journal for Parasitology, 2004
- Improved LC method to determine ivermectin in plasmaJournal of Pharmaceutical and Biomedical Analysis, 2003
- A review of the use of ivermectin as a treatment for sea lice [Lepeophtheirus salmonis (Krøyer) and Caligus elongatus Nordmann] infestation in farmed Atlantic salmon (Salmo salar L.)Aquaculture Research, 2000
- Bioequivalence of ivermectin formulations in pigs and cattleJournal of Veterinary Pharmacology and Therapeutics, 1999
- Comparative pharmacokinetics of doramectin and ivermectin in cattleVeterinary Parasitology, 1997
- Persistence of Ivermectin in Plasma and Faeces Following Treatment of Cows with Ivermectin Sustained-release, Pour-on or Injectable FormulationsInternational Journal for Parasitology, 1996
- The absorption, distribution and elimination of anthelmintic drugs: the role of pharmacokineticsJournal of Veterinary Pharmacology and Therapeutics, 1994
- Pharmacokinetics of ivermectin after oral or percutaneous administration to adult milking goatsJournal of Veterinary Pharmacology and Therapeutics, 1990
- Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equationsJournal of Pharmacokinetics and Biopharmaceutics, 1978